Our Founders

Professor
Alan McNeill

Founder, Chief Medical Officer,

Consultant Urological Surgeon

 

Alan McNeill has worked at every stage of the patient care pathway in urological surgery in both private and public practice. He has published over 100 peer-reviewed papers and abstracts. He has successfully received almost £2m in grant funding, and has experience in developing and protecting IP.

Professor
Bob Reuben

Founder, Chief Technical Officer,

Professor of Materials Engineering of Heriot-Watt University

 

Professor of Materials Engineering of Heriot-Watt UniversityBob Reuben is an expert in the fields of mechanical engineering, bioengineering, microfabrication and sensor development. He has published over 200 peer-reviewed articles and managed several high value and high impact research studies supported by UK and EU research councils.

Mr Philip Rainey

Interim CEO

Philip is an experienced CEO with corporate and hands-on expertise in establishing and driving operational excellence within new start-ups and established enterprises. 

His experiences and skill sets compliment those of the other team members and he provides the necessary leadership to take this venture forward.

Mr Daniel Good

Founder, Medical Director,

Consultant Urological Surgeon

 

Daniel Good has spent over ten years working in clinical urological practice. Daniel has spent the last three years establishing the effectiveness of the ProstaPalp test.

Ms Femi Johnson

Founder, Technical Director

Femi is an MEng graduate of mechanical engineering, who has been working with prototype ProstaPalp devices for 2 years.

 

She has developed a manufacturing protocol for probes and has been using advanced manufacturing techniques to optimise sensor sensitivity. Femi has also been working with research nurses develop the system to hand-over status.

Professor David Sigsworth OBE FRSE

Chairman

Having served on the Board of a FTSE 100 company David also has 20 years experience of new start technology ventures. He is currently Chairman of the Central Market Agency and Senior Non-executive Director of Sigma Capital Group plc. He brings his extensive commercial experience, energy, enthusiasm and industry connections to the team.

Contact us 

IntelliPalpDx specialises in instrumented palpation and the diagnosis and management of prostate cancer

© 2020 IntelliPalp Dx